Valneva SE Ownership | Who Owns Valneva SE?
Valneva SE Ownership Summary
Valneva SE is owned by 6.85% institutional investors, and 93.15% retail investors. Novo is the largest institutional shareholder, holding 3.05% of VALN shares. AlphaCentric Life Sciences & Hlthcare I is the top mutual fund, with 0.15% of its assets in Valneva SE shares.
VALN Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Valneva SE | 6.85% | - | 93.15% |
| Sector | Healthcare Stocks | 42.50% | 10.81% | 46.69% |
| Industry | Biotech Stocks | 45.24% | 10.75% | 44.01% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Novo | 2.35M | 3.05% | $28.61M |
| Frazier life sciences management | 2.29M | 2.98% | $27.96M |
| General american investors | 354.36K | 0.46% | $4.32M |
| Wells fargo & company/mn | 153.99K | 0.20% | $1.88M |
| Morgan stanley | 32.99K | 0.04% | $402.44K |
| Marshall wace, llp | 31.21K | 0.04% | $380.78K |
| Ironwood investment management | 25.14K | 0.03% | $306.65K |
| Jpmorgan chase | 10.18K | 0.01% | $124.18K |
| Vsm wealth advisory | 9.00K | 0.01% | $109.80M |
| Gamma investing | 2.12K | 0.00% | $25.83K |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Novo | 2.35M | 1.84% | $28.61M |
| Frazier life sciences management | 2.29M | 0.84% | $27.96M |
| General american investors | 354.36K | 0.25% | $4.32M |
| Ironwood investment management | 25.14K | 0.13% | $306.65K |
| Vsm wealth advisory | 9.00K | 0.03% | $109.80M |
| Gamma investing | 2.12K | 0.00% | $25.83K |
| Wells fargo & company/mn | 153.99K | 0.00% | $1.88M |
| Alphamark advisors | 150.00 | 0.00% | $1.00K |
| Marshall wace, llp | 31.21K | 0.00% | $380.78K |
| Advisor group | 555.00 | - | $6.77K |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Frazier life sciences management | 2.29M | 0.84% | 833.33K |
| Marshall wace, llp | 31.21K | 0.00% | 31.21K |
| Morgan stanley | 32.99K | - | 24.95K |
| Jpmorgan chase | 10.18K | - | 10.18K |
| Vsm wealth advisory | 9.00K | 0.03% | 5.00K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Alphacentric advisors | - | - | -118.00K |
| Wells fargo & company/mn | 153.99K | 0.00% | -91.19K |
| Novo | 2.35M | 1.84% | -30.00K |
| Marex group | - | - | -11.30K |
| Advisor group | 555.00 | - | -1.30K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Marshall wace, llp | 31.21K | 0.00% | 31.21K | $380.78K |
| Jpmorgan chase | 10.18K | - | 10.18K | $124.18K |
| Barclays | 196.00 | - | 196.00 | $2.39K |
Sold Out
| Holder | Change |
|---|---|
| Qube research | -22.00 |
| Raymond james financial | -41.00 |
| Federation des caisses desjardins du quebec | -200.00 |
| Ridgewood investments | -550.00 |
| Marex group | -11.30K |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 30, 2025 | 17 | 6.25% | 5,273,598 | 17.79% | 6 | 80.96% | 11 | 37.50% | 3 | - |
| Jun 30, 2025 | 18 | 38.46% | 4,521,059 | 581.73% | 2 | 1581.74% | 10 | 66.67% | 3 | 50.00% |
| Mar 31, 2025 | 13 | 18.18% | 663,174 | -7.81% | - | 144.15% | 6 | 50.00% | 2 | 100.00% |
| Dec 31, 2024 | 8 | -20.00% | 292,740 | -59.21% | - | 74.76% | 3 | -25.00% | - | - |
| Sep 30, 2024 | 10 | - | 717,704 | 9.83% | - | 246.13% | 4 | - | - | -100.00% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| AlphaCentric Life Sciences & Hlthcare I | 118.00K | 0.15% | 29.75K |
| AlphaCentric LifeSci Healthcare I | 88.25K | 0.11% | 26.25K |
| Fidelity Nasdaq Composite Index | 2.88K | 0.00% | - |
VALN Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools